Summary Maternal factors including atopy and smoking during pregnancy are associated with asthma risk during childhood. Suggested mechanisms include transmission of specific maternal alleles and maternal influences on the intrauterine environment. We have previously shown that polymorphism in glutathione Stransferase, GSTP1 is associated with airway hyperresponsiveness (AHR) and atopy in adults. We now hypothesise that GSTP1 genotypes in the mother and child, but not the father, mediate asthma phenotypes in the child. One hundred and forty-five Caucasian families were recruited via an asthmatic proband aged 7-18 years. Atopy and asthma were assessed using a questionnaire, skin prick testing, serum IgE, spirometry and methacholine challenge (PC 20 , dose-response slopeFDRS). GSTP1 genotyping was determined using PCR. GSTP1 Val 105 /Val 105 genotype in the child was associated with a reduced risk of atopy ðP ¼ 0:038Þ and AHR (PC 20 , P ¼ 0:046; DRS, P ¼ 0:032). In mothers ðP ¼ 0:014Þ but not fathers ðP ¼ 0:623Þ; Val 105 /Val 105 was associated with a reduced risk of AHR in the child. We have identified, for the first time, an association between maternal genotype and the child's asthma phenotype that appears not to be due to transmission of specific maternal alleles. This preliminary data supports the view of in utero effects of maternal genotype and adds new insights into the possible mechanisms by which maternal factors may influence development of childhood asthma.
The association of maternal but not paternal genetic variation in GSTP1 with asthma phenotypes in children During gestation, mother and foetus may be exposed to agents that can adversely affect foetal development. For example, maternal smoking during pregnancy is associated with impaired foetal airway growth and an increased risk of asthma and wheezing in later life. 1 It is likely therefore, that the effectiveness of maternal systems that detoxify potentially harmful chemicals will significantly influence proper foetal development. The detoxication of many drugs and environmental electrophiles is catalysed by enzymes that are encoded by polymorphic genes such as those that comprise the glutathione S-transferase (GST) supergene family. 2 Maternal alleles may influence foetal well-being if they influence the catalytic effectiveness of detoxifying enzymes encoded by maternal genes or, if high risk alleles are transmitted to affected offspring with greater frequency than would be expected by Mendelian inheritance. 3 The latter appears to result from the selective inactivation of genetic material from one parent in all but the germ cells of the foetus (genetic imprinting). Thus, in the context of atopy, children of atopic mothers are more likely to develop the trait than those with atopic fathers and, atopy is more common in the mothers than the fathers of children with asthma. 4 , 5 Cookson et al. 6 first showed that in sibling pairs, atopy was linked to transmission of alleles from maternal but not paternal, 11q13 chromosomes.
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Inherited differences in paternal genes may also potentially influence the effect of maternal exposure on foetal development. Genes expressed in the placenta are paternal in origin. 7 Thus, their enzyme products may provide further defence against foetal exposure to exogenous toxins.
The finding that alleles located on chromosome 11q13 are associated with risk of atopy in the child is important as this chromosomal region is a hotspot for asthma-related genes. Although the high affinity IgE receptor is accepted by many as being important in atopy, the associations with other asthma phenotypes are less well-defined and it has been suggested that many candidates are too distant to account for the strength of the identified associations to this region from whole genome screens. 8, 9 We recently showed, in two independent studies in adults, that polymorphism in GSTP1, a gene located on chromosome 11q13, is associated with risk of airway hyperresponsiveness (AHR) and atopy. 10, 11 GSTP1 is strongly expressed in human foetal lung during gestation and its expression can be regulated by methylation, a key mechanism in the selective allele inactivation seen in genetic imprinting. 2, 12 Its enzyme product, GSTP1-1, catalyses the detoxification of many environmental toxins and by-products of oxidative stress.
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GSTP1 is polymorphic with allelic variants demonstrating different catalytic efficiencies due to changes in the active site. 13, 14 In addition to the wild-type, GSTP1 * A allele, GSTP1 * B; GSTP1 * C and GSTP1 * D have been identified. GSTP1 * B contains an A-G transition, resulting in an Ile 105 -Val
105
(I105V) change while GSTP1 * D contains a C-T transition giving rise to an Ala 114 -Val 114 (A114V) substitution. GSTP1 * C contains both these transitions. Enzymes with the valine at amino acid 105 have a seven-fold higher catalytic efficiency for diol epoxides of polycyclic aromatic hydrocarbons (PAH), than the isoenzymes with the isoleucine at this position. In contrast, the Val 105 enzyme is three-fold less effective using 1-chloro-2,4-dinitrobenzene as substrate. 15, 16 There is no evidence to date of a functional effect of the A114V substitution alone (GSTP1 * D), although it is suggested that it augments the increased PAH activity of the I105V substitution (GSTP1 * C). 16 However, we were unable to identify any additional effect from the A114V substitution in previous studies on asthma phenotypes in adults and accordingly, focus only on the I105V substitution. 17 Although genetic studies have examined the transmission of atopy-associated alleles from mother to child, there is little data on the effect of maternal genetic factors on development of other asthma phenotypes such as AHR. The finding that GSTP1 is associated with AHR and atopy in adult asthmatics, its location on chromosome 11q13 and its utilisation of endogenous and exogenous chemicals as substrates prompts the suggestion that risk of asthma phenotypes in children is determined by an interaction between parental and foetal GSTP1 genotypes. Thus, allelic variants in this gene could directly influence the intrauterine environment by the catalytic effectiveness of maternal, paternal and/or foetal genotypes. While there are data linking maternal factors to chromosome 11q13, these have concentrated on transmission of maternal alleles to the child, rather than the effect of maternal genotype. Further, while maternal factors are known to be important in utero, the influence of maternal genetic polymorphisms on development of asthma phenotypes in the child is unknown. The aims of this study are to: (i) determine whether GSTP1 genotypes are associated with risk of the asthma associated phenotypes, atopy and AHR in children, (ii) establish whether maternal and/or paternal genotype affects this risk to a greater extent than expected by Mendelian inheritance, and (iii) determine whether the mechanism for the association reflects transmission of specific parental alleles to the child or provides evidence for a direct effect of maternal genotype on the intrauterine environment.
Methods Patients
One hundred and forty-five unrelated nuclear families were recruited via an asthmatic proband aged 7-18 years. The recruitment strategy has been described previously. 18 All families comprised Northern European Caucasians of British origin (English, Scottish or Welsh) for at least 3 generations and resident in North Staffordshire. All probands had doctor diagnosed asthma and a history of wheeze for at least 12 months. The presence of asthma in parents (32% of mothers, 26% of fathers) was also based on a doctor diagnosis. Subjects with cardiac, other respiratory or inflammatory diseases were excluded. Whilst we attempted to recruit mother, father and proband from each family (435 individuals), 4 fathers refused to participate resulting in a study group of 431 subjects ( Table 1 ). The study was approved by the local research ethics committee and written informed consent was obtained from all participants.
All subjects completed a standardised observeradministered ISAAC questionnaire, 19 modified by additional questions about asthma treatment, hospital admissions and viral illnesses. Responses were used to stratify subjects into 1 of 6 predefined categories; non-asthmatic, viral-induced wheeze, asthma (mild, moderate, severe, unclassified). All probands were asthmatic and none had viralinduced wheeze.
Baseline spirometry 20 and methacholine challenge testing (tidal breathing method) 21 were performed in all probands. The response to methacholine was expressed as a PC 20 and a dose-response slope (DRS). 22 PC 20 and DRS results were corrected for the child's age, gender, height, atopic status and baseline FEV 1 , FVC, FEV 1 /FVC and FEF (see Statistical analysis). A corrected PC 20 o8 mg/ml was used to define AHR. Where methacholine challenge was contraindicated (FEV 1 o 70%) probands underwent bronchodilator challenge. 20 Skin prick testing (SPT) and measurement of total serum IgE (Immulite assay, Euro/DPC Ltd, Gwynedd, Wales UK) were performed on all subjects. Atopy was defined as a positive response to SPT (X1 whealX3 mm greater than saline in response to a panel of 7 aeroallergens) or a total serum IgEX100 IU/ml.
GSTP1 genotyping
Genotyping was performed by staff unaware of the clinical status of the subjects. GSTP1 genotypes were determined using primers to exon 5 to identify the Ile105Val substitution. 10, 11 Fifteen percent of samples were re-assayed to confirm genotype assignments.
Statistical analysis
Chi-squared tests were used to assess associations between GSTP1 genotype and AHR, atopy, SPT positivity and IgEX100 IU/ml. 20 values were divided into 4 categories, 0-3.9, 4-7.9, 8-15.9 and X16 mg/ml as described previously. 10 These categories were selected as they best reflect the thresholds used to define AHR in the literature. Correction of PC 20 category and DRS for baseline parameters was then performed using discriminant and linear regression analyses, respectively. [23] [24] [25] Linear regression of DRS against baseline parameters generated the equation:
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.946. Associations of GSTP1 genotype with continuous variables (IgE, corrected DRS) were assessed using the Mann-Whitney U-test. Multivariate logistic regression was used to explore the relationships between parent and child genotypes, parental transmission and confounding factors such as maternal smoking. Transmission disequilibrium testing (TDT) was performed as described by Sham. 26 All statistical analyses were performed using the NCSS version 5 (Discriminant analysis; Number Cruncher Statistical Systems, Kaysville, UT) or Stata version 7: (All other analyses; Stata Corporation, College Station, TX) statistical packages. Table 1 shows the characteristics of the 431 individuals. DNA from two subjects (one mother, one father) failed to amplify. Atopic status was determined in 429/431 individuals and AHR status in 144/145 probands. AHR status was obtained by bronchodilator challenge in 13 and by methacholine challenge in 122 probands. Four probands discontinued methacholine challenge prior to a set end point. Of these, 3 showed a convincing response to bronchodilator (415% increase in FEV 1 ). It was therefore possible to obtain DRS values on 126 probands. A further 9 probands showed a 420% fall in FEV 1 following the inhalation of saline. All 13 on whom AHR status was obtained by bronchodilator challenge had current asthma and were defined as AHR positive. It was possible to obtain a corrected DRS and PC 20 category for all probands.
Results
Associations between GSTP1 genotype and AHR and atopy in probands GSTP1 genotype frequencies in parents and probands were similar to those previously reported in control subjects from North Staffordshire 10 and achieved Hardy-Weinburg equilibrium (Table 2  and 3 ). In probands, GSTP1 genotype was associated with corrected AHR (AHR c ) status, with was not significantly associated with a reduced risk of either SPT positivity or total serum IgEX100 IU/ml when these were considered individually (Table 2) , odds ratios were similar to that of the combined atopy variable. Using TDT analysis, no significant associations were identified between transmitted GSTP1 alleles and AHR c ðP ¼ 0:286Þ and atopy ðP ¼ 0:756Þ:
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Relationship between parental GSTP1 genotype and AHR and atopy in the child Maternal (but not paternal) GSTP1 genotype was significantly associated with both AHR c and atopy in Table 3 ). The association with AHR c was also found when analysis was restricted to atopy positive probands (P ¼ 0:061; odds ratio 0.28, 95% CI 0.05-1.44) although the numbers of subjects was reduced ðn ¼ 116Þ: There was insufficient data to examine this association in atopy negative probands. Significant associations were not observed for paternal genotype, although the odds ratios for maternal and paternal genotype and SPT positivity were similar ( Table 3 ).

The effect of maternal and paternal transmission of GSTP1 Val 105 alleles to the child
Assuming the transmission of a single GSTP1 allele from each parent, it was possible to determine which GSTP1 allele in the child came from which parent (parental transmission) in 136/145 probands. The remaining 8 families were triple heterozygotes (each of the child, mother and father were Ile 105 /Val 105 heterozygotes) and it was therefore not possible to determine parental transmission. No significant associations were seen between maternal or paternal transmission of Val 105 alleles and atopy or AHR c in the child (Table 4) .
Assessment of the inter-relationship between GSTP1 genotype and transmitted alleles
To assess the relative contribution to risk from parental and child genotypes and transmitted alleles, multivariate logistic regression was used (Table 5 ). This showed that only child and maternal genotype achieved or approached significance for AHR c in the child. Similar, but non-significant results were observed with SPT, IgE and overall atopic status (Table 5 ). This suggests that the genotype of both the mother and the child have a significant independent effect on the child's AHR c and atopic status. There was no evidence of a significant independent association with allele transmission. Using a TDT approach, no significant differences between the proportion of transmitted and non-transmitted Val 105 alleles from mothers and fathers were identified using either AHR c ðP ¼ 0:978Þ or atopy ðP ¼ 0:655Þ as endpoints.
The interaction between maternal and child genotypes was further explored by comparing pairs of subjects in which both mother and child had the Although the trend was maintained, the significance of the association between maternal genotype and AHR c in the child was reduced after correction for the child's atopic status (odds ratio (95% CI) ¼ 0.33(0.1-1.12), P ¼ 0:075).
Discussion
We have previously reported associations between GSTP1 Val 105 /Val 105 and reduced risk of asthma, atopy and AHR in two adult populations. 10, 11 In this study, we have shown that: (i) corresponding associations with AHR and atopy also appears to be present in children, (ii) maternal GSTP1 genotype also is significantly associated with AHR and atopy in the child, (iii) the effect of maternal genotype appears independent of the child's genotype, (iv) paternal GSTP1 genotype had no effect on the child's phenotype, and (v) these differences cannot be explained by preferential transmission of maternal alleles to the child and may therefore be due to the effect of maternal genotype on the child's intrauterine environment. Although we have previously shown an association in adults with atopic and occupational asthma, this is the first study to explore the relationship between AHR, atopy and GSTP1 genotype in children. The results for AHR and atopy are similar to, if slightly weaker than, those we reported in adults. 10, 11 This study shows a three-fold reduction in risk in both AHR and atopy in association with the Val 105 /Val 105 genotype in children. This compares with five-, four-and 10-fold reductions in risk of AHR, SPT positivity and IgEX100 IU/ml reported in adults. 10 The relationship between GSTP1, a gene that is believed to influence the response to oxidative stress, and asthma, an inflammatory disease of the airways, can be explained by the central role of oxidative stress in airway inflammation in adults and children. 27, 28 The mechanism by which the enzyme may influence atopy is less clear. Since the products of oxidative stress (e.g. lipid hydroperoxides) promote arachidonic acid mobilisation and eicosanoid synthesis, 29 GSTP1 may also influence the synthesis of eicosanoids by modulating levels of these products. 2 This pro-inflammatory cascade leads to the release of mediators and stimulation of Th 2 lymphocytes resulting in activation of mast cells, B-cells and eosinophils with increased release of histamine and production of IgE. Furthermore, eicosanoids are substrates for GSTP1, 2 suggesting a more direct role in the synthesis of these mediators.
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This preliminary study also shows that AHR c and, to a lesser extent, atopy in children appears to be influenced by maternal but not paternal genotype. We found no evidence that this is due to preferential transmission of maternal GSTP1 alleles to the child. It is possible, therefore, that the greater maternal effect is due to the effects that the maternal genotype exerts on the child's intrauterine environment. GSTP1 polymorphisms have been shown to influence GSTP1 activity [13] [14] [15] [16] and therefore the ability to detoxify exogenous toxins and the products of oxidative stress. It is possible that mothers with a reduced ability to detoxify exogenous pollutants expose their foetus to more toxins resulting in damage to the developing lung. For example, exposure of the foetus to cigarette smoke is associated with decreased airway growth, reduced maximal expiratory flow at functional residual capacity (V max FRC) at birth and an increased risk of wheeze and asthma in childhood. 1 The GSTP1 enzyme can utilise various potentially toxic chemicals present in cigarette smoke such as PAH and acrolein. 2 Children whose mothers have impaired/less effective GSTP1-1 function may therefore be at increased risk of the effects of maternal smoking during pregnancy, including wheeze and asthma. They may also be at risk from a wide variety of other environmental toxins. It was not possible to explore this hypothesis further in this study as only 15 mothers admitted smoking during pregnancy and data on other environmental exposures were not available. In a secondary analysis, we examined associations between proband and parental genotype on lung function (FEV 1 , FVC, FEF , FEV 1 /FVC) in the child. No significant associations were identified (data not shown), although this may reflect the importance of genes involved in airway remodelling, rather than those responsible for detoxification or protection against oxidative stress.
The results of the TDT analyses confirm the expected lack of association between maternal and paternal transmitted alleles and risk in the child. However, given that the case-control analysis showed a significant association between GSTP1 genotype in the child and risk of both atopy and AHR c , it may have been expected that the TDT association with transmitted versus non-transmitted Val 105 alleles would be significant. The reasons for the lack of significance may be either due to small numbers of trios, or due to the confounding effect of the association between maternal genotype and risk in the child.
Oxidative stress has pleiotrophic effects in the lung. In addition to the role of oxidants in airway epithelial cell injury, there is evidence that intracellular redox is important in determining the balance between Th 1 -and Th 2 -mediated immunity. 30, 31 Redox potential is regulated by the intracellular ratio of oxidised to reduced glutathione (GSSG:GSH ratio) and several studies have identified a relationship between this ratio and cytokine expression in different lung cells. [31] [32] [33] GSH depletion is linked with increased expression of cytokines associated with a pro-inflammatory state (e.g. TNFa; IL-12). [31] [32] [33] Furthermore, the GSSG:GSH ratio is increased by Th 1 (interferon-g) and decreased by Th 2 -associtated (IL-4) cytokines. 32 Studies in mice have shown that levels of GSH in antigen-presenting cells have a direct effect on the Th 1 /Th 2 cytokine response pattern with GSH depletion inhibiting Th 1 -associated cytokine production and favouring Th 2 -responses. 31 We speculate therefore, that the level of expression of glutathione-metabolising enzymes, such as GSTP1, may be associated with a persistence of Th 2 -mediated immunity resulting in asthma, atopy and allergic disease in childhood. This is supported by studies showing firstly, that expression of GSTP1 is regulated by redox status 34 and secondly, the transition from Th 2 -Th 1 immunity in childhood may be influenced by events in early pregnancy when expression of GSTP1-1 in foetal lung is high relative to that in adults. 12 This study includes relatively small numbers of children who do not have AHR or atopy which may explain the slightly unusual relationship between maternal, paternal and child atopy. Rather than maternal atopy predominating, similar numbers of mothers (83%) and fathers (84%) of atopic children were themselves atopic. The associations between AHR c and atopy and the child's GSTP1 genotype are, however, consistent in the study and compare well with those reported in adults. 10, 11 SPT and IgE may measure different phenotypic characteristics and combining them to define an overall 'atopy phenotype' can be criticised. This approach has, however, been used in many other studies and, to avoid confusion in this study, the results of SPT and IgE measurement are also presented individually. It is possible that the identified associations with AHR c may be influenced by the inclusion of atopy in the correction models. To explore this, we also assessed associations between GSTP1 and AHR corrected for the child's age, gender, height, and baseline FEV 1 , FVC, FEV 1 /FVC and FEF , but not atopic status. Similar results were obtained for maternal AHR c (PC 20c , P ¼ 0:071; DRS c , P ¼ 0:026) and paternal AHR c (PC 20c , P ¼ 0:562; DRS c , P ¼ 0:407), although the association between AHR c and GSTP1 genotype in the child was lost (PC 20c , P ¼ 0:441; DRS c , P ¼ 0:115).
The analysis exploring synergy between maternal and child Val 105 /Val 105 genotype was based on only 9 maternal-child pairs and it is possible that the apparent lack of association between parental transmission of GSTP1 alleles to the child was also due to small numbers. However, post hoc power calculations, based on maternal allele transmission and the affected: unaffected ratios observed, suggested that 133 and 167 probands were needed to identify associations (odds ratios of p0.25 as identified in previous studies) between maternal GSTP1 genotype and AHR c and atopy in the child with 80% power and 95% significance. These sample sizes compared well with the 145 probands studied. However, due to the small number of subjects in some groups, these data should be treated with caution until confirmation in further groups is performed. This is particularly true for the maternal genotype effect since this is the first study to identify this association. In the context of the effect of the child's GSTP1 genotype on risk, although the magnitude of the effect observed in children is smaller than that seen in adults, the fact that the association has been confirmed in three independent populations adds weight to these observations. Indeed, as such this association fulfils many of the essential requirements absent in most case-control studies. 35 In summary, this study confirms that GSTP1 genotype in both children and their mothers is associated with a reduced risk of atopy and AHR in schoolchildren. The effect of maternal genotype appears independent of the child's genotype and not due to preferential transmission of maternal alleles to the child. Maternal GSTP1 genotype may influence atopy and AHR in the child by altering the child's intrauterine environment.
